Division
HEAL Study
Title
The TAPS Tool: Screen and Brief Assessment Tool Validation Study
Short Description
A study to develop and validate a questionnaire to screen and assess adult primary care patients for tobacco, alcohol, prescription drug, and drug use and problems related to their use.
Release Date
Sep 14, 2017
Description

This study seeks to develop and validate a 4-item screen and a two-stage screening and brief assessment tool to screen and assess primary care patients for tobacco, alcohol, prescription drug, and illicit substance use and problems related to their use. The screen and two-stage screening and brief assessment tool (the latter hereafter called the Tobacco, Alcohol, Prescription medications, and other Substance [TAPS] tool) will be evaluated via self-administration and via interviewer-administration.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents
Case Report Form(s)
Deidentification Notes
Nulled Values
All Documents
Division
HEAL Study
Investigator(s)
Title
Testing and Linkage to HIV Care in China: A Cluster Randomized Trial
Short Description
This study will evaluate the effects of a comprehensive approach (One4All) to increase the percentage of patients that receive their HIV testing results and counseling.
Release Date
Sep 14, 2017
Description

This study will evaluate the effects of a comprehensive diagnostic approach to enhance the percentage of participants that receive their HIV testing results and counseling, given they are HIV positive on the initial EIA screening. All enrolled participants will be followed for 12 months with the viral load (VL) measured at that time point in addition to the status of any HIV treatment they have received.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents
Case Report Form(s)
Deidentification Notes
Nulled Values
All Documents

Smokeless Tabacco Questionnaire

Submitted by administrator on
Abbreviation
STQ
Description

Data are collected on thepast 3 months use of smokeless tobacco products: use of any smokeless tobacco product more that 5 times a day; more than 10 times a day; usual use within 30 minutes after waking; use of e-cigarettes, and if so, how many times per day.

Category
Substance Use
Subcategory
Tobacco

Oral Fluid Drug Test

Submitted by administrator on
Abbreviation
OFDT
Description

Oral fluid sample testing for amphetamines, methamphetamine (MDMA), cocaine/metabolite, opiates, oxycodone, phencyclidine, THC, barbiturates, benzodiazepines, and methadone. Samples can be analyzed by enzyme immunoassay (EIA). Oral fluid testing has been found to have adequate reliability compared to urine testing. (Bosker & Huestis, 2009; Cone & Huestis, 2007)

Category
Substance Use
Subcategory
Drugs

Alcohol, Smoking and Substance Involvement Screening Test

Submitted by administrator on
Abbreviation
ASSIST
Description

The ASSIST is an 8-item questionnaire developed by an international group of substance abuse researchers for the World Health Organization. It's purpose is to detect psychoactive substance use and related problems among primary care patients. The ASSIST provides information about: the substances people have ever used in their lifetime; the substances they have used in the past three months; problems related to substance use; risk of current or future harm; level of dependence; and injecting drug use. Substances addressed include: tobacco, alcohol, cannabis, cocaine, amphetamine type stimulants, sedatives, hallucinogens, inhalants, opioids, and other drugs.

Category
Substance Use
Subcategory
Tobacco
Alcohol
Drugs

Composite International Diagnositc Interview - Substance Abuse Module

Submitted by administrator on
Abbreviation
CIDI-SAM
Description

The SAM is an expanded and more detailed version of the substance use section of the CIDI. The four diagnostic sections cover tobacco, alcohol, drugs, and caffeine. The drug section include amphetamines and other stimulants, cannabinoids, cocaine, PCP and other hallucinogens, inhalants, heroin and other opiates, barbiturates and other sedatives and tranquilizers. The SAM includes questions about onset and recency of specific symptoms, as well as the specific withdrawal symptoms and physical, social, and psychological consequences for each category of substances used. Also included are the quantity and frequency of both the heaviest and past 12 month use, and ages associated with use and remission. The SAM also assesses the respondent’s impairment and treatment seeking.

Category
Substance Use
Subcategory
Tobacco
Alcohol
Drugs